Overview
The BDC2.5 Mimotope 1040-31 is a highly effective agonistic peptide specifically designed for the diabetogenic T cell clone BDC2.5. This unique mimotope stimulates BDC2.5 transgenic T cells, making it an essential tool for your research on diabetes and T cell responses.
This peptide has earned recognition as p31, underscoring its targeted specificity for BDC2.5 TCR Tg+ cells. If you are investigating diabetes pathogenesis or testing T cell activity, this peptide is an invaluable addition to your laboratory.
Key Features
- Strongly agonistic peptide for BDC2.5 T cell clone
- Stimulates a robust response in BDC2.5 transgenic T cells
- Also known as p31
- Essential for diabetes research and T cell studies
- Available in a convenient 1 mg quantity
Specifications
| Property | Details |
|---|---|
| Catalog Number | BDC2.5 Mimotope 1040-31 |
| Amount | 1 mg |
| Type | Peptide |
| Application | Research, T cell stimulation |
FAQ
What is BDC2.5 Mimotope 1040-31 used for?
This peptide is primarily used to stimulate BDC2.5 T cells, making it crucial for research focused on diabetes and T cell response mechanisms.
How does this peptide stimulate T cells?
The BDC2.5 Mimotope 1040-31 mimics the natural antigens recognized by BDC2.5 TCR Tg+ cells, thus provoking a significant T cell response.
What other products can complement my research?
You may find our PKG Substrate and Autocamtide-2 highly beneficial alongside this peptide in your studies on T cell activation and signaling.
Explore more peptides in our collection to enhance your research effectively. With the BDC2.5 Mimotope 1040-31 at your disposal, you can contribute to vital discoveries in the field of diabetes.
Related Products
Browse more in Peptides.




Reviews
There are no reviews yet.